TY - JOUR
T1 - Biological Investigations of Ru(II) Complexes with Diverse β-Diketone Ligands
AU - Ryan, Raphael T.
AU - Havrylyuk, Dmytro
AU - Stevens, Kimberly C.
AU - Moore, L. Henry
AU - Parkin, Sean
AU - Blackburn, Jessica S.
AU - Heidary, David K.
AU - Selegue, John P.
AU - Glazer, Edith C.
N1 - Publisher Copyright:
© 2021 Wiley-VCH GmbH.
PY - 2021/9/21
Y1 - 2021/9/21
N2 - The β-diketone scaffold is a commonly used synthetic intermediate, and is a functional group found in natural products such as curcuminoids. This core structure can also act as a chelating ligand for a variety of metals. In order to assess the potential of this scaffold for medicinal inorganic chemistry, seven different κ2-O,O’-chelating ligands were used to construct Ru(II) complexes with polypyridyl co-ligands, and their biological activity was evaluated. The complexes demonstrated promising structure-dependent cytotoxicity. Three complexes maintained high activity in a tumor spheroid model, and all complexes demonstrated low in vivo toxicity in a zebrafish model. From this series, the best compound exhibited a ∼30-fold window between cytotoxicity in a 3-D tumor spheroid model and potential in vivo toxicity. These results suggest that κ2-O,O’-ligands can be incorporated into Ru(II)-polypyridyl complexes to create favorable candidates for future drug development.
AB - The β-diketone scaffold is a commonly used synthetic intermediate, and is a functional group found in natural products such as curcuminoids. This core structure can also act as a chelating ligand for a variety of metals. In order to assess the potential of this scaffold for medicinal inorganic chemistry, seven different κ2-O,O’-chelating ligands were used to construct Ru(II) complexes with polypyridyl co-ligands, and their biological activity was evaluated. The complexes demonstrated promising structure-dependent cytotoxicity. Three complexes maintained high activity in a tumor spheroid model, and all complexes demonstrated low in vivo toxicity in a zebrafish model. From this series, the best compound exhibited a ∼30-fold window between cytotoxicity in a 3-D tumor spheroid model and potential in vivo toxicity. These results suggest that κ2-O,O’-ligands can be incorporated into Ru(II)-polypyridyl complexes to create favorable candidates for future drug development.
KW - Antitumor agents
KW - Cytotoxicity
KW - Photophysics
KW - Ruthenium
UR - http://www.scopus.com/inward/record.url?scp=85111910421&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85111910421&partnerID=8YFLogxK
U2 - 10.1002/ejic.202100468
DO - 10.1002/ejic.202100468
M3 - Article
AN - SCOPUS:85111910421
SN - 1434-1948
VL - 2021
SP - 3611
EP - 3621
JO - European Journal of Inorganic Chemistry
JF - European Journal of Inorganic Chemistry
IS - 35
ER -